NEW YORK--(BUSINESS WIRE)--Bragar Eagel & Squire, P.C. is investigating potential claims against USANA Health Sciences, Inc. (NYSE:USNA) concerning possible violations of the federal securities laws.
On February 7, 2017, post-market, USANA disclosed that the Company is “voluntarily conducting an internal investigation of its China operations, BabyCare Ltd. The investigation focuses on compliance with the Foreign Corrupt Practices Act . . . and certain conduct and policies at BabyCare, including BabyCare’s expense reimbursement policies.”
Following this news, USANA shares declined $7.25 per share, or over 11.5%, on February 8, 2017 to close at $55.40.
If you purchased or otherwise acquired USANA securities and suffered a loss, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact J. Brandon Walker, Esq. by email at email@example.com, or telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.
Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information concerning our investigation into USANA, please go to www.bespc.com/usana. For additional information about Bragar Eagel & Squire, P.C., please go to www.bespc.com.